Contract facts
Small businessADVANCING MILITARY HEALTHCARE: NOVEL ZWITTERIONIC HYDROGELS FOR ENHANCED WOUND HEALING IN COMBAT-RELATED BURN INJURIES is a federal Small business award for Fa8649 Usaf Sbir Sttr Contracting held by Gelsana Therapeutics Inc. Estimated value $1.2M ($1.2M obligated). Current period of performance ends Oct 7, 2026. Last award drew 198 bidders. Place of performance: AURORA CO.
ADVANCING MILITARY HEALTHCARE: NOVEL ZWITTERIONIC HYDROGELS FOR ENHANCED WOUND HEALING IN COMBAT-RELATED BURN INJURIES
Recompete timing
PublicCurrent PoP ends Oct 7, 2026 (10 days remaining). Agencies typically plan 12–18 months ahead — at 0.3 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on FA864924P0508? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordGelsana Therapeutics Inc — $1.2M obligated across 1 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract FA864924P0508?
FA864924P0508 (Advancing military healthcare: NOVEL) is a Fa8649 Usaf Sbir Sttr Contracting award with a potential value of $1.2M, currently held by Gelsana Therapeutics Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is FA8649-24-P-0508?
FA8649-24-P-0508 is the dashed form of PIID FA864924P0508 (Advancing military healthcare: NOVEL), held by Gelsana Therapeutics Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded FA864924P0508?
Fa8649 Usaf Sbir Sttr Contracting awarded FA864924P0508 to Gelsana Therapeutics Inc (potential $1.2M).
Who is the incumbent on FA864924P0508?
Gelsana Therapeutics Inc is the incumbent with $1.2M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Oct 7, 2026.
When does Gelsana Therapeutics Inc’s FA864924P0508 come up for recompete?
SCOUT tracks a period-of-performance end of Oct 7, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on FA864924P0508? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.